AIM/HYPOTHESIS: This study was designed to determine whether type 2 diabetic adolescents have reduced aerobic capacity and to investigate the role of cardiac output and arteriovenous oxygen difference (a-vO(2)) in their exercise response. METHODS: Female adolescents (age 12-18 years) with type 2 diabetes mellitus (n = 8) and type 1 diabetes mellitus (n = 12) and obese (n = 10) and non-obese (n = 10) non-diabetic controls were recruited for this study. Baseline data included maximal aerobic capacity (cycle ergometer) and body composition. Cardiac output and a-vO(2) were determined at rest and during submaximal exercise. RESULTS: Diabetic groups had lower aerobic capacity than non-diabetic groups (p < 0.05). Adolescents with type 2 diabetes had lower aerobic capacity than the type 1 diabetic group. Maximal heart rate was lower in the type 2 diabetic group (p < 0.05). Exercise stroke volume was 30-40% lower at 100 and 120 beats per min in the diabetic than in the non-diabetic groups (p < 0.05). The a-vO(2) value was not different in any condition. CONCLUSIONS AND INTERPRETATION: Type 2 diabetic adolescents have reduced aerobic capacity and reduced heart rate response to maximal exercise. Furthermore, type 2 and type 1 diabetic adolescent girls have a blunted exercise stroke volume response compared with non-diabetic controls. Central rather than peripheral mechanisms contribute to the reduced aerobic capacity in diabetic adolescents. Although of short duration, type 2 diabetes in adolescence is already affecting cardiovascular function in adolescents.
AIM/HYPOTHESIS: This study was designed to determine whether type 2 diabetic adolescents have reduced aerobic capacity and to investigate the role of cardiac output and arteriovenousoxygen difference (a-vO(2)) in their exercise response. METHODS: Female adolescents (age 12-18 years) with type 2 diabetes mellitus (n = 8) and type 1 diabetes mellitus (n = 12) and obese (n = 10) and non-obese (n = 10) non-diabetic controls were recruited for this study. Baseline data included maximal aerobic capacity (cycle ergometer) and body composition. Cardiac output and a-vO(2) were determined at rest and during submaximal exercise. RESULTS:Diabetic groups had lower aerobic capacity than non-diabetic groups (p < 0.05). Adolescents with type 2 diabetes had lower aerobic capacity than the type 1 diabetic group. Maximal heart rate was lower in the type 2 diabetic group (p < 0.05). Exercise stroke volume was 30-40% lower at 100 and 120 beats per min in the diabetic than in the non-diabetic groups (p < 0.05). The a-vO(2) value was not different in any condition. CONCLUSIONS AND INTERPRETATION: Type 2 diabetic adolescents have reduced aerobic capacity and reduced heart rate response to maximal exercise. Furthermore, type 2 and type 1 diabetic adolescent girls have a blunted exercise stroke volume response compared with non-diabetic controls. Central rather than peripheral mechanisms contribute to the reduced aerobic capacity in diabetic adolescents. Although of short duration, type 2 diabetes in adolescence is already affecting cardiovascular function in adolescents.
Authors: Gerhard Pichler; Berndt Urlesberger; Paul Jirak; Heinz Zotter; Elke Reiterer; Wilhelm Müller; Martin Borkenstein Journal: Diabetes Care Date: 2004-08 Impact factor: 19.112
Authors: Allison Longenberger; Jeong Youn Lim; Trevor Orchard; Maria Mori Brooks; Jennifer Brach; Kristen Mertz; Lawrence A Kingsley Journal: Futur HIV Ther Date: 2008-11
Authors: Judith G Regensteiner; Timothy A Bauer; Amy G Huebschmann; Leah Herlache; Howard D Weinberger; Eugene E Wolfel; Jane E B Reusch Journal: Med Sci Sports Exerc Date: 2015-01 Impact factor: 5.411
Authors: Carly S Gordon; Antonio S Serino; Matthew P Krause; Jonathan E Campbell; Enzo Cafarelli; Olasunkanmi A J Adegoke; Thomas J Hawke; Michael C Riddell Journal: PLoS One Date: 2010-11-17 Impact factor: 3.240
Authors: Petter Bjornstad; Uyen Truong; Laura Pyle; Jennifer L Dorosz; Melanie Cree-Green; Amy Baumgartner; Gregory Coe; Judith G Regensteiner; Jane E B Reusch; Kristen J Nadeau Journal: J Diabetes Complications Date: 2016-04-13 Impact factor: 2.852